Skip to main content

Advertisement

Log in

Association Study of Transforming Growth Factor Beta 1 + 29 T/C exon 1 Polymorphism in Breast Cancer Patients from North Indian Population

  • Original Article
  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Background: TGFB1 cytokine is involved in normal mammary epithelial development as well as in breast tumorigenesis. It has role in both breast tumor suppression and progression. TGFB1 gene has several single nucleotide polymorphisms (SNPs) many of which modulate the activity of TGFB1. Our aim in this study was to analyze TGFB1 + 29 polymorphism in breast cancer individuals from North Indian population. Methods: TGFB1 + 29 T/C polymorphism was analyzed using Sanger sequencing in 285 breast cancer patients and age matched 363 healthy controls from North Indian population. Next, transcript expression of 13 apoptotic genes, TRAIL, DR4, DR5, DcR1, DcR2, Bcl2, cytochrome c, Casp8L, Casp8, FlipS, FlipL, Casp3s and Casp3 were carried out in 77 breast tumor tissues obtained from 77 individuals. Results: TGFB1 + 29 CC genotype provided protection against the development of breast cancer (P = 0.012). This was mainly attributable to higher age group (> 45 years) women (P = 0.016). Individuals having CC protector genotype showed significantly higher expression of TGFB1 transcript compared to the TT and TC risk genotypes (P = 0.044). Furthermore, we observed that TGFB1 + 29 CC genotype showed increased TRAIL mediated apoptosis via the extrinsic pathway in breast tumor patients with age greater than 45 years (P = 0.027). Conclusion: TGFB1 + 29 homozygous mutant CC genotype is related to protection against breast cancer in North Indian women population greater than 45 years of age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The data that supports the findings of this study are available from the corresponding author, RP, upon reasonable request.

References

  1. Muraoka-Cook, R. S., Dumont, N., & Arteaga, C. L. (2005).Clin Cancer Res11,937s-943s

    Article  Google Scholar 

  2. Dranoff, G. (2004).Nat Rev Cancer4,11–22

    Article  CAS  PubMed  Google Scholar 

  3. Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018).Bone Res6,2

    Article  PubMed  PubMed Central  Google Scholar 

  4. Goumans, M. J., Liu, Z., & ten Dijke, P. (2009).Cell Res19,116–127

    Article  CAS  PubMed  Google Scholar 

  5. Hata, A., & Chen, Y. G. (2016).Cold Spring Harb Perspect Biol8

  6. Massague, J. (2012).Nat Rev Mol Cell Biol13,616–630

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Roberts, A. B., & Wakefield, L. M. (2003).Proc Natl Acad Sci U S A100,8621–8623

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Seoane, J., & Gomis, R. R. (2017).Cold Spring Harb Perspect Biol9

  9. Ahn, Y. O., Lee, J. C., Sung, M. W., & Heo, D. S. (2009).J Immunol182,6114–6120

    Article  CAS  PubMed  Google Scholar 

  10. Khoshakhlagh, M., Soleimani, A., Binabaj, M. M., Avan, A., Ferns, G. A., Khazaei, M., & Hassanian, S. M. (2019).Biochem Pharmacol164,17–22

    Article  CAS  PubMed  Google Scholar 

  11. Moore-Smith, L. D., Isayeva, T., Lee, J. H., Frost, A., & Ponnazhagan, S. (2017).Sci Rep7,8678

    Article  PubMed  PubMed Central  Google Scholar 

  12. Falschlehner, C., Emmerich, C. H., Gerlach, B., & Walczak, H. (2007).Int J Biochem Cell Biol39,1462–1475

    Article  CAS  PubMed  Google Scholar 

  13. Johnstone, R. W., Frew, A. J., & Smyth, M. J. (2008).Nat Rev Cancer8,782–798

    Article  CAS  PubMed  Google Scholar 

  14. Ashkenazi, A. (2008).Nat Rev Drug Discov7,1001–1012

    Article  CAS  PubMed  Google Scholar 

  15. Himeji, D., Horiuchi, T., Tsukamoto, H., Hayashi, K., Watanabe, T., & Harada, M. (2002). Blood 99, 4070–4078

  16. Vegran, F., Boidot, R., Oudin, C., Riedinger, J. M., Bonnetain, F., & Lizard-Nacol, S. (2006).Clin Cancer Res12,5794–5800

    Article  CAS  PubMed  Google Scholar 

  17. Herzer, K., Ganten, T. M., Schulze-Bergkamen, H., Grosse-Wilde, A., Koschny, R., Krammer, P. H., & Walczak, H. (2005).Hepatology42,183–192

    Article  CAS  PubMed  Google Scholar 

  18. Sanchez-Capelo, A. (2005).Cytokine Growth Factor Rev16,15–34

    Article  CAS  PubMed  Google Scholar 

  19. Saltzman, A., Munro, R., Searfoss, G., Franks, C., Jaye, M., & Ivashchenko, Y. (1998).Exp Cell Res242,244–254

    Article  CAS  PubMed  Google Scholar 

  20. Shima, Y., Nakao, K., Nakashima, T., Kawakami, A., Nakata, K., Hamasaki, K., Kato, Y., Eguchi, K., & Ishii, N. (1999).Hepatology30,1215–1222

    Article  CAS  PubMed  Google Scholar 

  21. Cao, Y., Chen, L., Zhang, W., Liu, Y., Papaconstantinou, H. T., Bush, C. R., Townsend, C. M. Jr., Thompson, E. A., & Ko, T. C. (2007).Am J Physiol Gastrointest Liver Physiol292,G28-38

    Article  PubMed  Google Scholar 

  22. Lafon, C., Mathieu, C., Guerrin, M., Pierre, O., Vidal, S., & Valette, A. (1996).Cell Growth Differ7,1095–1104

    CAS  PubMed  Google Scholar 

  23. Cano-Gonzalez, A., & Lopez-Rivas, A. (2016).Biochim Biophys Acta1863,2104–2114

    Article  CAS  PubMed  Google Scholar 

  24. Bedi, A., Chang, X., Noonan, K., Pham, V., Bedi, R., Fertig, E. J., Considine, M., Califano, J. A., Borrello, I., Chung, C. H., Sidransky, D., & Ravi, R. (2012).Mol Cancer Ther11,2429–2439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zhang, S., Ekman, M., Thakur, N., Bu, S., Davoodpour, P., Grimsby, S., Tagami, S., Heldin, C. H., & Landstrom, M. (2006).Cell Cycle5,2787–2795

    Article  CAS  PubMed  Google Scholar 

  26. Li, Y., Liu, Y., Chiang, Y. J., Huang, F., Li, Y., Li, X., Ning, Y., Zhang, W., Deng, H., & Chen, Y. G. (2019).Cell Rep28,735–745e734

    Article  CAS  PubMed  Google Scholar 

  27. Kim, M. R., Lee, J., An, Y. S., Jin, Y. B., Park, I. C., Chung, E., Shin, I., Barcellos-Hoff, M. H., & Yi, J. Y. (2015).Mol Cancer Res13,319–329

    Article  CAS  PubMed  Google Scholar 

  28. Davies, A. A., Masson, J. Y., McIlwraith, M. J., Stasiak, A. Z., Stasiak, A., Venkitaraman, A. R., & West, S. C. (2001).Mol Cell7,273–282

    Article  CAS  PubMed  Google Scholar 

  29. Li, J., Zhu, H., Chen, T., Dai, G., & Zou, L. (2011).Cell Biochem Biophys60,245–248

    Article  CAS  PubMed  Google Scholar 

  30. Lin, W. W., & Karin, M. (2007).J Clin Invest117,1175–1183

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Wang, L., Tong, X., Zhou, Z., Wang, S., Lei, Z., Zhang, T., Liu, Z., Zeng, Y., Li, C., Zhao, J., Su, Z., Zhang, C., Liu, X., Xu, G., & Zhang, H. T. (2018).Mol Cancer17,140

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wu, Y., Zhao, J., & He, M. (2015).Tumour Biol36,5149–5156

    Article  CAS  PubMed  Google Scholar 

  33. Colakogullari, M., Ulukaya, E., Yilmaztepe Oral, A., Aymak, F., Basturk, B., Ursavas, A., & Oral, H. B. (2008).Cell Biochem Funct26,283–290

    Article  CAS  PubMed  Google Scholar 

  34. Alqumber, M. A., Dar, S. A., Haque, S., Wahid, M., Singh, R., & Akhter, N. (2014).Asian Pac J Cancer Prev15,8725–8734

    Article  PubMed  Google Scholar 

  35. Huang, Y., Li, B., Qian, J., Xie, J., & Yu, L. (2010).Breast Cancer Res Treat123,863–868

    Article  CAS  PubMed  Google Scholar 

  36. Krishna, B. M., Jana, S., Panda, A. K., Horne, D., Awasthi, S., Salgia, R., & Singhal, S. S. (2020). Cancers (Basel) 12

  37. Ziv, E., Cauley, J., Morin, P. A., Saiz, R., & Browner, W. S. (2001).JAMA285,2859–2863

    Article  CAS  PubMed  Google Scholar 

  38. Pal, R., Gochhait, S., Chattopadhyay, S., Gupta, P., Prakash, N., Agarwal, G., Chaturvedi, A., Husain, N., Husain, S. A., & Bamezai, R. N. (2011).Breast Cancer Res Treat126,333–343

    Article  PubMed  Google Scholar 

  39. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002).Genome Biol3,RESEARCH0034

    Article  PubMed  PubMed Central  Google Scholar 

  40. Dunning, A. M., Ellis, P. D., McBride, S., Kirschenlohr, H. L., Healey, C. S., Kemp, P. R., Luben, R. N., Chang-Claude, J., Mannermaa, A., Kataja, V., Pharoah, P. D., Easton, D. F., Ponder, B. A., & Metcalfe, J. C. (2003).Cancer Res63,2610–2615

    CAS  PubMed  Google Scholar 

  41. Hishida, A., Iwata, H., Hamajima, N., Matsuo, K., Mizutani, M., Iwase, T., Miura, S., Emi, N., Hirose, K., & Tajima, K. (2003).Breast Cancer10,63–69

    Article  PubMed  Google Scholar 

  42. Gonzalez-Zuloeta Ladd, A. M., Arias-Vasquez, A., Siemes, C., Coebergh, J. W., Hofman, A., Witteman, J., Uitterlinden, A., Stricker, B. H., & van Duijn, C. M. (2007).Eur J Cancer43,371–374

    Article  CAS  PubMed  Google Scholar 

  43. Lee, K. M., Park, S. K., Hamajima, N., Tajima, K., Yoo, K. Y., Shin, A., Noh, D. Y., Ahn, S. H., Hirvonen, A., & Kang, D. (2005).Breast Cancer Res Treat90,149–155

    Article  CAS  PubMed  Google Scholar 

  44. Pooja, S., Francis, A., Rajender, S., Tamang, R., Rajkumar, R., Saini, K. S., Megu, K., Goel, M. M., Surekha, D., Rao, D. R., Rao, L., Ramachandra, L., Kumar, S., Kumar, S., Vishnupriya, S., Satyamoorthy, K., Negi, M. P., Thangaraj, K., & Konwar, R. (2013).PLoS One8,e75979

    Article  PubMed  PubMed Central  Google Scholar 

  45. Yokota, M., Ichihara, S., Lin, T. L., Nakashima, N., & Yamada, Y. (2000).Circulation101,2783–2787

    Article  CAS  PubMed  Google Scholar 

  46. Arteaga, C. L., Dugger, T. C., & Hurd, S. D. (1996).Breast Cancer Res Treat38,49–56

    Article  CAS  PubMed  Google Scholar 

  47. Reiss, M., & Barcellos-Hoff, M. H. (1997).Breast Cancer Res Treat45,81–95

    Article  CAS  PubMed  Google Scholar 

  48. Pasche, B., Kolachana, P., Nafa, K., Satagopan, J., Chen, Y. G., Lo, R. S., Brener, D., Yang, D., Kirstein, L., Oddoux, C., Ostrer, H., Vineis, P., Varesco, L., Jhanwar, S., Luzzatto, L., Massague, J., & Offit, K. (1999).Cancer Res59,5678–5682

    CAS  PubMed  Google Scholar 

  49. Tang, B., Bottinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998).Nat Med4,802–807

    Article  CAS  PubMed  Google Scholar 

  50. Zheng, W. (2009).Methods Mol Biol472,265–277

    Article  CAS  PubMed  Google Scholar 

  51. Anderson, W. F., Pfeiffer, R. M., Dores, G. M., & Sherman, M. E. (2006).Cancer Epidemiol Biomarkers Prev15,1899–1905

    Article  PubMed  Google Scholar 

  52. Balducci, L., & Beghe, C. (2001).Crit Rev Oncol Hematol37,137–145

    Article  CAS  PubMed  Google Scholar 

  53. Ershler, W. B., & Longo, D. L. (1997).J Natl Cancer Inst89,1489–1497

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Prof. R.N.K Bamezai (Jawaharlal Nehru University, New Delhi, India) for providing research facilities for carrying out the research work, critically reading and commenting on the manuscript which is based on the thesis work of RP carried out at Jawaharlal Nehru University, New Delhi, India (http://hdl.handle.net/10603/14169). We acknowledge Dr. Pawan Gupta of Dharamshila Cancer Hospital and Research Centre, Delhi, Dr. Neeraj Prakash from Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India and Dr. Gaurav Agarwal from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India for providing the authors with the samples to carry out the research work in breast cancer biology. The authors further thank the patient and control subjects for their participation.

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ranjana Pal.

Ethics declarations

Ethics Approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Jawaharlal Nehru University.

Informed Consent

was obtained from all individual participants included in the study.

Competing Interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Fig. 1

Categorization of gene expression belonging to extrinsic and intrinsic apoptotic pathways (TRAIL, DR4, DR5, Casp8, Casp3, TRAIL, DcR1, DcR2, Casp8L, FlipL, FlipS, Casp3s, Cytochrome c, Casp3, Bcl2, Casp3s) with respect to age (≤ 45 and > 45 years) which are further categorized with respect to TGFB1 + 29 genotype. * indicates p value less than equal to 0.05. # indicates p value less than equal to 0.09 but more than 0.05. Error bars represents standard error.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pal, R., Dutta, S. Association Study of Transforming Growth Factor Beta 1 + 29 T/C exon 1 Polymorphism in Breast Cancer Patients from North Indian Population. Appl Biochem Biotechnol 195, 3671–3680 (2023). https://doi.org/10.1007/s12010-023-04438-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-023-04438-5

Keywords

Navigation